If people with viral loads above 1000 copies/ml on an existing first-line regimen and women intending to have children were excluded from dolutegravir treatment, only 43% of adults living with HIV would receive dolutegravir over a 20-year period. If only women intending to have children were excluded from dolutegravir treatment, 54% would receive the drug.… Read More »
The authors place the post-AIDS increase in STIs within a historic context. Gonorrhoea cases in the UK have been recorded since 1918 and syphilis since 1922, when the UK’s network of free and confidential STI clinics was set up. This was after a Royal Commission on Venereal Diseases (as STIs used to be called) recommended… Read More »
FDA Approves Dextenza (dexamethasone ophthalmic insert) for the Treatment of Ocular Pain Following Ophthalmic Surgery Print this page BEDFORD, Mass.–(BUSINESS WIRE)–Dec. 3, 2018– Ocular Therapeutix™, Inc. a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the U.S. Food and Drug Administration… Read More »
An ultra low-calorie diet that can reverse type 2 diabetes is to form part of a pilot run by the NHS in England. The 800-calorie a day diet using liquid meals and shakes will be prescribed for three months, initially to 5,000 people, and follow-up support given. Nine out of 10 people with diabetes in… Read More »
There are no treatment options approved for peanut allergy, which is commonly found in American children. But new findings presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting and published in The New England Journal of Medicine reveal that a therapy to protect people with this allergy is awaiting review… Read More »